Antheia, Inc.’s Post

🚀 Breaking News Alert: Revolutionizing Drug Discovery with AI-Powered Chemistry! 💊 Exciting developments are reshaping the landscape of drug discovery! Our latest article unveils a breakthrough AI-powered chemistry platform that's revolutionizing the way we develop life-saving medications. 👉 Dive into the article here: [Breakthrough Alert: AI-Powered Chemistry Platform Revolutionizes Drug Discovery](https://lnkd.in/dr84GWVm) Discover how cutting-edge technology is accelerating the identification of promising drug candidates, reducing costs, and enhancing efficiency in the pharmaceutical industry. Join the conversation and share your thoughts in the comments below. This is a game-changer for healthcare innovation! #DrugDiscovery #AI #Innovation 🧪

According to Pharmaphorum, a groundbreaking collaboration between ETH Zurich researchers, Roche scientists, and other experts has resulted in the development of a cutting-edge algorithm. This algorithm leverages the power of artificial intelligence (AI) to rapidly design novel active pharmaceutical ingredients. What's even more impressive is that it does so by analyzing the three-dimensional surface of proteins.  https://lnkd.in/dA7XaKGi

✨NEW BLOG ― BIOANALYTICAL METHOD DEVELOPMENT: HIGH PH MOBILE PHASE Explore how we've shattered the 'volatility barrier' much like the sound barrier was broken, leading to revolutionary advancements in drug development. Discover the power of LC-MS in various industries and why high pH mobile phases are a game-changer for analyzing basic drugs. Ready to expand your knowledge? ✍️ Written by: Hongzhi Liu and Dr. Nicola (Nicki) Hughes Learn more here 👇 https://hubs.li/Q02v9tqH0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #genericdrugs #biotech #pharmaceuticalindustry

Enthusiasm for incorporating #AI in pharmaceutical research is rapidly growing with firms specializing in this field doubled the investments they secured. #Isomorphic is making strides in developing #foundationalmodels for understanding biology and chemistry and not just "simply" using AI to analyze existing data. I really enjoyed this #FT Article DeepMind spin-off aims to halve drug discovery times following Big Pharma deals https://lnkd.in/dZJ2JvBx

#AIinPredictiveToxicology Market is estimated to register a CAGR of over 29.5% between 2023 and 2032. The increasing investments in pharmaceutical AI startups are driving the market growth. These funds enable the development and implementation of advanced technologies, such as Machine Learning (ML) and predictive modeling, to enhance toxicological assessments of chemical compounds. Read More: https://lnkd.in/dMwDxaVb Key players: Cyclica Instem Exscientia Biovista #Bioinformatics #Toxicityprediction #Structuralalerts #Dataintegration #Riskassessment

🔬 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐝𝐫𝐮𝐠2𝐝𝐫𝐮𝐠𝐬 𝐀𝐈-𝐀𝐀𝐌: 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐰𝐢𝐭𝐡 𝐀𝐈-𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐋𝐞𝐚𝐝 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 In the quest to accelerate drug development, our cutting-edge CRO service, 𝐝𝐫𝐮𝐠2𝐝𝐫𝐮𝐠𝐬 𝐀𝐈-𝐀𝐀𝐌, is set to transform the landscape of pharmaceutical and biotech drug research. By harnessing the power of advanced AI and chemical simulation, we offer an innovative solution to generate multiple active compounds from a single structure, providing up to 100 candidate compounds with diverse scaffolds, enhanced thermal stability, and optimal synthesizability. 𝐖𝐡𝐲 𝐝𝐫𝐮𝐠2𝐝𝐫𝐮𝐠𝐬 𝐀𝐈-𝐀𝐀𝐌? 𝐒𝐭𝐫𝐞𝐚𝐦𝐥𝐢𝐧𝐞𝐝 𝐋𝐞𝐚𝐝 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: Our innovative AI-AAM technology simplifies the lead optimization process, requiring only the structural information of the bioactive region of the compound. 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: Accelerate your drug development pipeline with our ability to quickly generate backup compounds and refine many aspects of existing drug molecules. 𝐂𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐭𝐢𝐚𝐥 𝐚𝐧𝐝 𝐒𝐞𝐜𝐮𝐫𝐞: We require little to no experimental data from the client to acquire results, and we prioritize the confidentiality and security of your data throughout the process. 𝐖𝐡𝐨 𝐂𝐚𝐧 𝐁𝐞𝐧𝐞𝐟𝐢𝐭? - Researchers and academia looking to push the boundaries of drug discovery. - Small to mid-size pharmaceutical and biotech companies aiming to expedite their drug development pipelines. - Agrochemical companies seeking innovative solutions for lead optimization. 𝐆𝐞𝐭 𝐒𝐭𝐚𝐫𝐭𝐞𝐝 𝐓𝐨𝐝𝐚𝐲 Explore how drug2drugs AI-AAM can enhance your drug discovery projects. Visit our website to learn more and send an inquiry: https://lnkd.in/eY4aFrxd. Let’s embark on a journey to redefine the possibilities of pharmaceutical innovation.

Global #3D_Cell_Culture_Microplates Market Poised for Significant Growth as Biotechnology Advances >> https://lnkd.in/ePxnpS8Q 3D #cell culture microplate is a next-generation #tool of choice for safety pharmacology and #drug screening purposes. It is designed to support the growth, #attachment, and differentiation of cells for ongoing #culture or temporarily before cell-based #assays. It is widely used in CROs, #biotech, pharmaceutical #companies, and fundamental #research in academic and government #laboratories. eNUVIO - Microfabricated Devices for Next-generation Cell Culture Creative Bioarray Biotek Ortho Thermo Fisher Scientific InSphero Biocroi Limited #healthcareindustry #pharmaceuticalindustry #healthcareresearch #biotechnology #3Dcell #culture #discovery #research 

Is AI the key to accelerating drug discovery? Possibly, but only if it’s implemented effectively. There’s many factors to consider, from the purpose of our algorithms, to the evidence metrics of success which we use. In our ebook, you’ll discover the key considerations which every leader needs to take in order to successfully implement AI in their drug discovery pipelines. Download now to read about the factors influencing AI adoption, the organisational changes necessary to make the most from AI systems in drug discovery, and the stories of AI success from large pharmaceutical and biotechnology companies. Download for free at https://lnkd.in/eXgs-xcQ

Are you carrying out research into the fascinating subject of post-translational modifications? Biosynth scientists have decades of experience in making PTM-specific reagents, and can create custom antibody tools against a variety of different modification types. Our extensive knowledge in this field will lead to the best chance of success for your projects, and may potentially open new paths for your research. See our slider below to discover the significant role of post-translational modifications in the modulation of cellular processes and disease. Visit our biologics webpage for an overview of our offering in the biologics field. https://lnkd.in/geJZd-a7 #posttranslationalmodifications #cellregulation #customsynthesis  #lifesciences  #biologics  #molecularbiology #antibody